United States
Germany
Japan
United Kingdom
China
beta 2 Microglobulin (B2M) rabbit polyclonal antibody, HRP
| Applications | ELISA, EM, IHC, WB |
| Reactivities | Human |
Antibodies
Human IgG (Fc specific) goat polyclonal antibody, HRP
| Applications | ELISA: 1/3000. Immunohistochemistry on Frozen Sections. |
| Reactivities | Human |
| Conjugation | HRP |
Human IgM (Mu chain specific) goat polyclonal antibody, HRP
| Applications | Suitable for Immunoblotting (Western or Dot blot), ELISA, Immunoperoxidase electron microscopy and Immunohistochemistry as well as other peroxidase-antibody based enzymatic assays requiring lot-to-lot consistency. Recommended Dilutions ELISA: 1/80,000. Western blot: 1/2,000-1/20,000. Immunohistochemistry: 1/500-1/2,500. |
| Reactivities | Human |
| Conjugation | HRP |
Human IgA + IgG + IgM goat polyclonal antibody, HRP
| Applications | Suitable for Immunoblotting (Western or dot blot), ELISA, Immunoperoxidase electron microscopy and Immunohistochemistry as well as other peroxidase-antibody based enzymatic assays requiring lot-to-lot consistency. Recommended Dilutions: ELISA: 1/20,000-1/100,000. Western blot: 1/2,000-1/10,000. Immunoprecipitation: 1/1,000-1/5,000. |
| Reactivities | Human |
| Conjugation | HRP |
Human IgE goat polyclonal antibody, HRP
| Applications | ELISA: 1/10000-1/100000. |
| Reactivities | Human, Monkey |
| Conjugation | HRP |
Human IgE (Fc specific) goat polyclonal antibody, HRP
| Applications | Enzyme-Immunocytochemical and Immunohistochemical staining for the detection of IgE at the cellular and subcellular level by staining of appropriately treated cell and tissue substrates. To demonstrate circulating IgE antibodies in serodiagnostic microbiology and autoimmune diseases. To identify a specific antigen using an reference antibody of Human origin known to be of the IgE isotype in the middle layer of the indirect test procedure. In non-isotopic assay methodology (e.g. ELISA) to measure IgE in Human serum or other body fluids. Recommneded Dilutions: Histochemistry and Cytochemistry: 1/50-1/250. ELISA and comparable non-precipitating antibody-binding assays: 1/1,000-1/25,000. |
| Reactivities | Human |
| Conjugation | HRP |
Collagen Type V Antibody Peroxidase Conjugated
| Applications | ELISA, IHC, IP, WB |
| Reactivities | Human |
Collagen Type II Antibody Peroxidase Conjugated
| Applications | ELISA, IHC, IP, WB |
| Reactivities | Human |
Collagen Type III Antibody Peroxidase Conjugated
| Applications | ELISA, IHC, IP, WB |
| Reactivities | Human |
Human IgD (Fc specific) goat polyclonal antibody, HRP
| Applications | Can be used in Enzyme-immunocytochemical and Immunohistochemical staining for the detection of IgD at the cellular and subcellular level by staining of appropriately treated cell and tissue substrates; to demonstrate circulating IgD antibodies in serodiagnostic microbiology and autoimmune diseases; in nonisotopic assay methodology (e.g. ELISA) to measure IgD in human serum or other body fluids. This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. Recommended working dilutions: Histochemical and Cytochemical: 1/50 - 1/500. ELISA and comparable non-precipitating antibody-binding assays: 1/500 - 1/10,000. |
| Reactivities | Human |
| Conjugation | HRP |
Human IgG (H&L) Antibody Peroxidase Conjugated
| Applications | WB: 1:5,000 - 1:25,000 IHC: 1:1,000 - 1:5,000 ELISA: 1:20,000 - 1:80,000 |
| Reactivities | Human |
| Conjugation | HRP |
活动过滤器
clear Category
- Antibodies
优化搜索结果
Target Symbol
Antibody Hosts
Assay Types
Families
Pathways
- Chemokine signaling pathway (2)
- Complement and coagulation cascades (2)
- Systemic lupus erythematosus (2)
- Cytokine-cytokine receptor interaction (1)
- Fc epsilon RI signaling pathway (1)
- Fc gamma R-mediated phagocytosis (1)
- GnRH signaling pathway (1)
- Neuroactive ligand-receptor interaction (1)
- Neurotrophin signaling pathway (1)
- Tight junction (1)
- Type II diabetes mellitus (1)
- Vascular smooth muscle contraction (1)
